Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2024 08:00 ET | Source: ImmuneSensor Therapeutics

ImmuneSensor Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations from the U.S. FDA for cGAS Inhibitor Drug Candidate, IMSB301, for the Treatment of Aicardi Goutières Syndrome (AGS)

Company is evaluating IMSB301 in a Phase 1 clinical trial in healthy volunteers and plans to move rapidly into Phase 1b/2 clinical studies in patients with AGS, lupus and other cGAS-driven diseases ...
October 17, 2024 09:08 ET | Source: Bipsync

Bipsync and Dasseti Partner to Streamline Research and Due Diligence Processes for Investment Management

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Bipsync, a premier research and workflow management platform, and Dasseti, a leading provider of custom data collection solutions, today announced a...
September 16, 2024 10:47 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for CAE, AAL, ODD, and LFCR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
September 14, 2024 21:00 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm

NEW YORK, Sept. 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
September 13, 2024 11:04 ET | Source: Faruqi & Faruqi LLP

Faruqi & Faruqi Reminds Oddity Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 17, 2024 - ODD

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Oddity To Contact Him Directly To Discuss Their Options If you...
September 10, 2024 21:00 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm

NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
September 09, 2024 15:35 ET | Source: Bernstein Liebhard LLP

ODDITY TECH LTD. (NASDAQ: ODD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Oddity Tech Ltd. Investors of Upcoming Deadline

ODDITY TECH LTD. (NASDAQ: ODD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Oddity Tech Ltd. Investors of Upcoming Deadline
September 09, 2024 12:17 ET | Source: The Rosen Law Firm PA

ODD DEADLINE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Oddity Tech Ltd. Investors to Secure Counsel Before Important September 17 Deadline in Securities Class Action - ODD

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Oddity Tech Ltd. (NASDAQ: ODD) between July 19, 2023 and...
September 09, 2024 12:06 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for CAE, AAL, ODD, and LFCR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
September 06, 2024 11:06 ET | Source: Faruqi & Faruqi LLP

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Oddity

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Oddity To Contact Him Directly To Discuss Their Options If you...

Next Page keyboard_arrow_right